Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP: Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders
Zh ., 1991, 63(5), 112-116
No anxiety-like behavior (Supplementary Fig
Aug 2020;31(8):570-579
For example, we and others have found that renal cancer cells (RCC) with loss of VHL (Von Hippel-Lindau), a tumor suppressor that destabilizes HIF1A via ubiquination, are significantly sensitive to ascorbate treatment compared to VHL-proficient cells
Tirzepatide, a dual GIP/GLP-1 agonist available as compounded injection ($289/mo) or oral tablet ($349/mo), engages a different pathway that some IBD patients tolerate betterthough individual responses vary